Table 2 Baseline characteristics and demographics of the population received adjuvant treatment. Data are expressed as numbers (percentage) or mean (range)
Adjuvant Chemo + CHMF | Adjuvant Chemo + Placebo | P-value | |
|---|---|---|---|
(n = 114) | (n = 115) | ||
Gender, n (%) | 0.596 | ||
Male | 57 (50%) | 61 (53%) | |
Female | 57 (50%) | 54 (47%) | |
Age | 59.4 ± 7.4 | 59.6 ± 7.5 | 0.861 |
ECOG PS, n (%) | 0.99 | ||
0 | 2 (1.8%) | 2 (1.7%) | |
1 | 111 (97.4%) | 112 (97.4%) | |
2 | 1 (0.8%) | 1 (0.9%) | |
Smoking history, n (%) | 0.224 | ||
Smoked | 40 (35.1%) | 50 (43.5%) | |
Never smoke | 74 (64.9%) | 65 (56.5%) | |
Resection procedure, n (%) | 0.333 | ||
Lobectomy | 108 (94.7%) | 112 (97.4%) | |
Sublobectomy | 6 (5.3%) | 3 (2.6%) | |
Video-assaciated, n (%) | 0.689 | ||
Yes | 64 (56.1%) | 68 (59.1%) | |
No | 50 (43.9%) | 47 (40.9%) | |
pTNM stage, n (%) | 0.998 | ||
Ib | 55 (48.2%) | 56 (48.7%) | |
II | 22 (19.3%) | 22 (19.1%) | |
III | 37 (32.5%) | 37 (32.2%) | |
Chemo regimens, n (%) | 0.688 | ||
NP | 48 (42.1%) | 45 (39.1%) | |
NC | 66 (57.9%) | 70 (60.9%) | |
TCM syndrome, n (%) | 0.862 | ||
Qi deficiency | 55 (56.1%) | 58 (50.4%) | |
Yin deficiency | 10 (8.8%) | 8 (7.0%) | |
Qi-Yin deficiency | 49 (35.1%) | 49 (42.6%) |